PRIMARY STUDY

The Therapeutic Aspects of the Endocannabinoid System (ECS) for Cancer and their Development: From Nature to Laboratory.

Key Findings:  The authors of this review suggest that CB1 may undergo modifications in renal tumors at the post-transcriptional level thus suggesting an increasing complexity and need for further studies to better understand the role of the ECS in renal cancers.